Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for Severe Perineal Laceration
NCT04573504Phase 4Recruiting
- Sponsor
- Northwestern University
- Start
- Sep 2020
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate, metronidazole, clindamycin in obstetric anal sphincter injury (OASI), sponsored by Northwestern University. Started Sep 2020; status: recruiting.
02
Drugs
amoxicillin + clavulanatemetronidazoleclindamycin
03
Conditions
obstetric anal sphincter injury (OASI)
Beyond the preview
Go deeper on NCT04573504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573504.